Identification of inguinofemoral lymph node metastases by methylation markers in vulvar cancer

Gynecologic Oncology

Volumn 125, Issue 2, 2012, Pages 352-357

  Oonk, M H M ^a   Eijsink, J J H ^a   Volders, H H ^a   Hollema, H ^a   Wisman, G B A ^a   Schuuring, E ^a   Van Der Zee, A G J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Lymph node metastases; Methylation; Sentinel node; Vulvar cancer

Indexed keywords

BIOLOGICAL MARKER; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; VULVA CANCER; VULVECTOMY;

AGED; AGED, 80 AND OVER; CELL ADHESION MOLECULES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENES, P16; GENETIC MARKERS; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULINS; IMMUNOHISTOCHEMISTRY; INGUINAL CANAL; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; TELOMERASE; TUMOR SUPPRESSOR PROTEINS; TWIST TRANSCRIPTION FACTOR; VULVAR NEOPLASMS;

EID: 84859615616     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2012.01.013     Document Type: Article

References (35)

1. Cancer statistics registration: Registrations of cancer diagnosed in 2006. England. National Statistics websitewww.statistics.gov.uk.
2. Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 4rd ed. Philadelphia: Williams and Wilkins; 2005. p. 543-83.
3. Van der Zee AG, Oonk MH, de Hullu JA, et al. Sentinel node dissection is safe in the treatment of early stage vulvar cancer. J Clin Oncol 2008;26:884-9. (Pubitemid 351398080)
4. Knopp S, Holm R, Tropé C, Nesland JM. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol Oncol 2005;99:383-7. (Pubitemid 41502848)
5. Narayansingh GV, Miller ID, Sharma M, et al. The prognostic significance of micrometastases in node-negative squamous cell carcinoma of the vulva. Br J Cancer 2005;92:222-4. (Pubitemid 40343132)
6. Oonk MH, van Hemel BM, Hollema H, et al. Size of sentinel-node metastasis and chances of non-sentinel node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010;11:646-52.
7. Lerma E, Esteller M, Herman JG, Prat J. Alterations of the p16INK4a/Rb/Cyclin-D1 pathway in vulvar carcinoma, vulvar intraepithelial neoplasia, and lichen sclerosus. Hum Pathol 2002;33:1120-5. (Pubitemid 35416710)
8. O'Nions J, Brooks LA, Sullivan A, et al. p73 is over-expressed in vulval cancer principally as the Delta 2 isoform. Br J Cancer 2001;85:1551-6. (Pubitemid 34001589)
9. Soufir N, Queille S, Liboutet M, et al. Inactivation of the CDKN2A and the p53 tumour suppressor genes is external genital carcinomas and their precursors. Br J Dermatol 2007;156:448-53.
10. Guerrero D, Guarch R, Ojer A, et al. Differential hypermethylation of genes in vulvar cancer and lichen sclerosus coexisting or not with vulvar cancer. Int J Cancer 2011;128:2853-64.
11. INK4ais an early event in vulval squamous neoplasia. Oncogene 2002;21:1876-81.
12. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6. (Pubitemid 26296693)
13. Brock MV, Hooker CM, Ota-Machida E, et al. DNA methylation markers and early stage recurrence in stage I lung cancer. NEJM 2008;358:1118-28. (Pubitemid 351398486)
14. Pellisé M, Castells A, Ginès A, et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonographyguided fine-needle aspiration biopsy. Clin Cancer Res 2004;10:4444-9. (Pubitemid 38878887)
15. Sanchez-Cespedes M, Esteller M, Hibi K, et al. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence. Clin Cancer Res 1999;5:2450-4. (Pubitemid 29437327)
16. Harden SV, Tokumaru Y, Westra WH, et al. Gene promotor hypermethylation in tumors and lymph nodes of stage I lung cancer patients. Clin Cancer Res 2003;9:1370-5. (Pubitemid 36418388)
17. Harder J, Engelstaedter V, Usadel H, et al. CpG-island methylation of the ER promotor in colorectal cancer: analysis of micrometastases in lymph nodes from UICC stage I and II patients. Br J Cancer 2009;100:360-5.
18. Hiraki M, Kitajima Y, Sato S, et al. Aberrant gene methylation in the lymph nodes provides a possible marker for diagnosing micrometastasis in gastric cancer. Ann Surg Oncol 2010;17:1177-86.
19. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun 1985;130: 118-26. (Pubitemid 15249008)
20. Wisman GB, Nijhuis ER, Hoque MO, et al. Assessment of gene promotor hypermethylation for detection of cervical neoplasia. Int J Cancer 2006;119: 1908-14. (Pubitemid 44356850)
21. Van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 2003;17:2257-317. (Pubitemid 38072572)
22. Yang N, Eijsink JJ, Lendvai A, et al. Methylation markers for CCNA1 and C13ORF18 are strongly associated with hihg-grade cervical intraepithelial neoplasie and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 2009;18: 3000-7.
23. Poetsch M, Hemmerich M, Kakies C, et al. Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 2011;458:221-9.
24. Park TJ, Han SU, Cho YK, et al. Methylation of O96)-methylguanine-DNA methyltransferase gene is associated significantlywith K-rasmutation, lymph node invasion, tumor staging, and disease free survival in patients with gastric carcinoma. Cancer 2001;92:2760-8. (Pubitemid 33091912)
25. Ito T, Shimada Y, Hashimoto Y, et al. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma. Cancer Res 2003;63:6320-6. (Pubitemid 37255179)
26. Esteller M, Hamilton SR, Burger PC, Baylin SB, Herman JG. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 1999;59:793-7. (Pubitemid 29086728)
27. Feng Q, Balasubramanian A, Hawes SE, et al. Detection of hypermethylated genes in women with an without cervical neoplasia. J Natl Cancer Inst 2005;97: 273-82. (Pubitemid 40310275)
28. Jansen M, Fukushima N, Rosty C, et al. Aberrant methylation of the 5′ CpG island of TSLC1 is common in pancreatic ductal adenocarcinomas and is first manifest in high-grade PanINs. Cancer Biol Ther 2002;1:293-6.
29. Sova P, Feng W, Geiss G, et al. Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis. Cancer Epidemiol Biomarkers Prev 2006;15:114-23.
30. Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84. (Pubitemid 32225381)
31. Sawhney M, Rohatgi N, Kaur J, et al. MGMT expression in oral precancerous and cancerous lesions: correlation with progression, nodal metastasis and poor prognosis. Oral Oncol 2007;43:515-22. (Pubitemid 46561437)
32. Cavalli LR, Urban CA, Dai D, et al. Genetic and epigenetic alterations in sentinel lymph nodes metastatic lesions compared to their corresponding primary breast tumors. Cancer Genet Cytogenet 2003;146:33-40. (Pubitemid 37117432)
33. Carraway HE, Wang S, Blackford A, et al. Promotor hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence. Breast Cancer Res Treat 2009;114:315-25.
34. Rastetter M, Schagdarsurengin U, Lahtz C, et al. Frequent intra-tumoural heterogeneity of promotor hypermethylation in malignant melanoma. Histol Histopathol 2007;22:1005-15. (Pubitemid 47034166)
35. Graff JR, Gabrielson E, Fujii H, Baylin SB, Herman JG. Methylation patterns of the Ecadherin 5′ CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression. J Biol Chem 2000;275: 2727-32. (Pubitemid 30082043)